Panacos Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Sep '08 Sep 30, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005	Dec '04 Dec 31, 2004	Dec '03 Dec 31, 2003
Cash & Equivalents	21.37	37.87	33.14	87.14	4.88	0.48
Short-Term Investments	5.52	14.03	27.63	-	-	-
Cash & Short-Term Investments	26.89	51.9	60.77	87.14	4.88	0.48
Cash Growth	-44.17%	-14.60%	-30.26%	1685.98%	923.92%	-72.09%
Accounts Receivable	0.1	0.15	0.07	0.39	-	-
Other Receivables	-	-	-	-	0.28	0.14
Receivables	0.1	0.15	0.07	0.39	0.28	0.14
Prepaid Expenses	0.53	1.06	2.15	1.09	0.06	0.06
Total Current Assets	27.52	53.1	62.98	88.61	5.22	0.68
Property, Plant & Equipment	0.84	1.05	2.12	2.35	0.31	0.35
Long-Term Deferred Charges	-	0.33	-	-	-	-
Other Long-Term Assets	1.38	1.24	0.55	0.61	0.8	0.19
Total Assets	29.74	55.71	65.65	91.57	6.33	1.22
Accounts Payable	1.17	2.98	3.23	1.91	0.47	0.65
Accrued Expenses	4.59	3.95	2.92	2.99	2.14	0.34
Short-Term Debt	-	-	-	-	-	2.95
Current Portion of Long-Term Debt	6.99	0.36	0.36	0.21	0.12	0.16
Current Portion of Leases	0.06	0.06	-	0.01	0.01	0.01
Other Current Liabilities	-	-	-	0.71	-	-
Total Current Liabilities	12.82	7.34	6.51	5.82	2.74	4.12
Long-Term Debt	11.1	18.8	-	-	0.03	0.15
Long-Term Leases	0.05	0.1	-	-	0.01	0.01
Other Long-Term Liabilities	0.5	0.6	0.46	0.15	0.08	0.06
Total Liabilities	24.47	26.84	6.97	5.97	2.86	4.34
Common Stock	0.54	0.54	0.53	0.5	0.02	0.01
Additional Paid-In Capital	191.16	188.35	180.71	169.88	0.67	-
Retained Earnings	-186.43	-160.02	-122.56	-84.45	-25.34	-13.05
Comprehensive Income & Other	0.01	0.01	0.01	-0.32	-1.79	-0
Total Common Equity	5.27	28.87	58.68	85.6	-26.45	-13.04
Shareholders' Equity	5.27	28.87	58.68	85.6	3.47	-3.13
Total Liabilities & Equity	29.74	55.71	65.65	91.57	6.33	1.22
Total Debt	18.21	19.31	0.36	0.21	0.16	3.29
Net Cash (Debt)	8.68	32.58	60.41	86.93	4.72	-2.82
Net Cash Growth	-77.93%	-46.06%	-30.51%	1743.58%	-	-
Net Cash Per Share	0.16	0.61	1.20	2.53	4.90	-6.99
Filing Date Shares Outstanding	53.64	53.54	52.85	50.13	1.45	0.65
Total Common Shares Outstanding	53.64	53.54	52.85	49.91	1.45	0.65
Working Capital	14.7	45.75	56.47	82.79	2.48	-3.44
Book Value Per Share	0.10	0.54	1.11	1.72	-18.21	-20.09
Tangible Book Value	5.27	28.87	58.68	85.6	-26.45	-13.04
Tangible Book Value Per Share	0.10	0.54	1.11	1.72	-18.21	-20.09
Buildings	-	-	-	2.23	0.09	0.09
Machinery	-	1.24	1.19	0.82	0.49	0.43
Leasehold Improvements	-	1.57	2.39	2.23	0.09	0.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.